Taiwan · Delayed Price · Currency is TWD Dr. Wu Skincare Statistics
Total Valuation
Dr. Wu Skincare has a market cap or net worth of TWD 5.34 billion. The enterprise value is 4.40 billion.
| Market Cap | 5.34B |
| Enterprise Value | 4.40B |
Important Dates
The next estimated earnings date is Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | Dec 4, 2025 |
Share Statistics
Dr. Wu Skincare has 45.05 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 45.05M |
| Shares Outstanding | 45.05M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 22.10% |
| Owned by Institutions (%) | 0.75% |
| Float | 16.63M |
Valuation Ratios
The trailing PE ratio is 13.28.
| PE Ratio | 13.28 |
| Forward PE | n/a |
| PS Ratio | 4.32 |
| PB Ratio | 3.69 |
| P/TBV Ratio | 3.69 |
| P/FCF Ratio | 16.86 |
| P/OCF Ratio | 16.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.79, with an EV/FCF ratio of 13.89.
| EV / Earnings | 10.90 |
| EV / Sales | 3.56 |
| EV / EBITDA | 8.79 |
| EV / EBIT | 8.94 |
| EV / FCF | 13.89 |
Financial Position
The company has a current ratio of 3.89, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.89 |
| Quick Ratio | 3.27 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.12 |
| Interest Coverage | 346.22 |
Financial Efficiency
Return on equity (ROE) is 27.02% and return on invested capital (ROIC) is 19.99%.
| Return on Equity (ROE) | 27.02% |
| Return on Assets (ROA) | 16.25% |
| Return on Invested Capital (ROIC) | 19.99% |
| Return on Capital Employed (ROCE) | 33.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.92 |
Taxes
In the past 12 months, Dr. Wu Skincare has paid 103.86 million in taxes.
| Income Tax | 103.86M |
| Effective Tax Rate | 20.46% |
Stock Price Statistics
The stock price has decreased by -20.74% in the last 52 weeks. The beta is 0.01, so Dr. Wu Skincare's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -20.74% |
| 50-Day Moving Average | 120.53 |
| 200-Day Moving Average | 128.73 |
| Relative Strength Index (RSI) | 42.53 |
| Average Volume (20 Days) | 36,918 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Wu Skincare had revenue of TWD 1.24 billion and earned 403.66 million in profits. Earnings per share was 8.92.
| Revenue | 1.24B |
| Gross Profit | 865.38M |
| Operating Income | 491.98M |
| Pretax Income | 507.52M |
| Net Income | 403.66M |
| EBITDA | 495.33M |
| EBIT | 491.98M |
| Earnings Per Share (EPS) | 8.92 |
Balance Sheet
The company has 977.04 million in cash and 39.44 million in debt, giving a net cash position of 937.60 million or 20.81 per share.
| Cash & Cash Equivalents | 977.04M |
| Total Debt | 39.44M |
| Net Cash | 937.60M |
| Net Cash Per Share | 20.81 |
| Equity (Book Value) | 1.45B |
| Book Value Per Share | 32.14 |
| Working Capital | 1.07B |
Cash Flow
In the last 12 months, operating cash flow was 321.02 million and capital expenditures -4.31 million, giving a free cash flow of 316.71 million.
| Operating Cash Flow | 321.02M |
| Capital Expenditures | -4.31M |
| Free Cash Flow | 316.71M |
| FCF Per Share | 7.03 |
Margins
Gross margin is 70.02%, with operating and profit margins of 39.81% and 32.66%.
| Gross Margin | 70.02% |
| Operating Margin | 39.81% |
| Pretax Margin | 41.06% |
| Profit Margin | 32.66% |
| EBITDA Margin | 40.08% |
| EBIT Margin | 39.81% |
| FCF Margin | 25.62% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 9.28%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 9.28% |
| Dividend Growth (YoY) | -9.09% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 122.76% |
| Buyback Yield | -0.32% |
| Shareholder Yield | 9.04% |
| Earnings Yield | 7.56% |
| FCF Yield | 5.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 26, 2016. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2016 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Dr. Wu Skincare has an Altman Z-Score of 12.26 and a Piotroski F-Score of 4.
| Altman Z-Score | 12.26 |
| Piotroski F-Score | 4 |